1. Home
  2. LTRN vs FENG Comparison

LTRN vs FENG Comparison

Compare LTRN & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • FENG
  • Stock Information
  • Founded
  • LTRN 2013
  • FENG 1998
  • Country
  • LTRN United States
  • FENG China
  • Employees
  • LTRN N/A
  • FENG N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • FENG Broadcasting
  • Sector
  • LTRN Health Care
  • FENG Industrials
  • Exchange
  • LTRN Nasdaq
  • FENG Nasdaq
  • Market Cap
  • LTRN 35.4M
  • FENG 29.7M
  • IPO Year
  • LTRN 2020
  • FENG 2011
  • Fundamental
  • Price
  • LTRN $3.11
  • FENG $2.36
  • Analyst Decision
  • LTRN Hold
  • FENG
  • Analyst Count
  • LTRN 1
  • FENG 0
  • Target Price
  • LTRN N/A
  • FENG N/A
  • AVG Volume (30 Days)
  • LTRN 77.7K
  • FENG 8.0K
  • Earning Date
  • LTRN 11-07-2024
  • FENG 11-12-2024
  • Dividend Yield
  • LTRN N/A
  • FENG N/A
  • EPS Growth
  • LTRN N/A
  • FENG N/A
  • EPS
  • LTRN N/A
  • FENG N/A
  • Revenue
  • LTRN N/A
  • FENG $99,426,474.00
  • Revenue This Year
  • LTRN N/A
  • FENG N/A
  • Revenue Next Year
  • LTRN N/A
  • FENG N/A
  • P/E Ratio
  • LTRN N/A
  • FENG N/A
  • Revenue Growth
  • LTRN N/A
  • FENG N/A
  • 52 Week Low
  • LTRN $2.79
  • FENG $1.20
  • 52 Week High
  • LTRN $11.99
  • FENG $4.15
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 41.22
  • FENG 41.10
  • Support Level
  • LTRN $3.28
  • FENG $2.32
  • Resistance Level
  • LTRN $3.60
  • FENG $2.70
  • Average True Range (ATR)
  • LTRN 0.43
  • FENG 0.19
  • MACD
  • LTRN -0.06
  • FENG -0.01
  • Stochastic Oscillator
  • LTRN 0.00
  • FENG 28.99

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.

Share on Social Networks: